Skip to main content
. 2024 Dec 24;24:428. doi: 10.1186/s12935-024-03600-1

Fig. 1.

Fig. 1

Circulating biomarkers and applications of liquid biopsy. A This section represents the conventional and potential circulating biomarkers identified in patients with HCC. B This section demonstrates the potential applications of liquid biopsy as a non-invasive strategy for managing HCC patients. Liquid biopsy offers a promising method for early diagnosis, prediction of therapy response, tumor monitoring, prognosis assessment and, molecular stratification